Brinker Capital Investments’s 10x Genomics TXG Stock Holding History

Brinker Capital Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Buy	+6,310	New	+$165K	﹤0.01%	1732
2025 Q3	–	Sell	-13,636	Closed	-$158K	–	2126
2025 Q2	$158K	Buy	+13,636	New	+$124K	﹤0.01%	1923
2022 Q3	–	Sell	-9,262	Closed	-$419K	–	1393
2022 Q2	$419K	Buy	+9,262	New	+$481K	0.01%	1041
2021 Q4	–	Sell	-1,740	Closed	-$341K	–	1438
2021 Q3	$341K	Hold	1,740	–	–	0.01%	1097
2021 Q2	$341K	Buy	+1,740	New	+$315K	﹤0.01%	1151
2021 Q1	–	Sell	-1,914	Closed	-$271K	–	1265
2020 Q4	$271K	Buy	+1,914	New	+$278K	﹤0.01%	947

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brinker Capital Investments's TXG Position: Q2 2026 in Review

Brinker Capital Investments opened a new position in 10x Genomics (TXG) in Q2 2026: 6,310 shares worth $242K. The stake represents ﹤0.01% of the portfolio and ranks #1732 among its holdings. This is a return to the name: Brinker Capital Investments previously reported a position in TXG as recently as Q2 2025.

Brinker Capital Investments first reported a position in TXG in Q4 2020 and has held it in 6 quarters since. The position peaked at $419K in Q2 2022. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Brinker Capital Investments held 6,310 shares of 10x Genomics worth $242K as of Q2 2026.
10x Genomics was a new Brinker Capital Investments position in Q2 2026.
10x Genomics made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1732 holding.
Brinker Capital Investments first reported a position in 10x Genomics in Q4 2020 and has held it in 6 quarters since.
Brinker Capital Investments's 10x Genomics position peaked at $419K in Q2 2022.
393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.